SageView Advisory Group, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1914558
NEWPORT BEACH, CA
Position in VRTX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$735,657
+$281,526 QoQ
Shares Held
1,481
+45.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#943
of 1,735 holders
Holding Since
Mar 2023
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SageView Advisory Group, LLC holds $735,657 across 1 Biotechnology name. VRTX ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,481 | $735,657 |
All Filings in VRTX
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $735,657 | 1,481 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $454,131 | 1,017 | Shares | Sole | 2026-08-10 | |
| 2025-12-31 | $590,274 | 1,302 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,291,237 | 3,297 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,711,794 | 3,845 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,928,613 | 3,978 | Shares | Sole | 2025-05-19 | |
| 2024-12-31 | $1,647,445 | 4,091 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,836,522 | 6,099 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,287,133 | 7,013 | Shares | Sole | 2024-08-15 | |
| 2023-12-31 | $2,588,634 | 6,362 | Shares | Sole | 2024-03-06 | |
| 2023-09-30 | $800,497 | 2,302 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $630,622 | 1,792 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $404,864 | 1,285 | Shares | Sole | 2023-05-02 | |
| No filing history on record for this holder in this stock. | ||||||